Literature DB >> 30882842

Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.

Mariana P Socal1, Ge Bai2, Gerard F Anderson1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30882842      PMCID： PMC6547248          DOI： 10.1001/jamainternmed.2018.7824

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2018-04-16

2.  Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.

Authors:  Stacie B Dusetzina; Rena M Conti; Nancy L Yu; Peter B Bach
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873
  2 in total
  5 in total

1.  Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.

Authors:  Aishwarya Vijay; Ravi Gupta; Patrick Liu; Sanket S Dhruva; Nilay D Shah; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2019-10-17       Impact factor: 5.128

2.  Pharmacy switching in response to preferred pharmacy networks in Medicare Part D.

Authors:  Jianhui Xu; Erin Trish; Geoffrey Joyce
Journal:  Health Serv Res       Date:  2022-03-30       Impact factor: 3.734

3.  Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available.

Authors:  Stacie B Dusetzina; Juliette Cubanski; Leonce Nshuti; Sarah True; Jack Hoadley; Drew Roberts; Tricia Neuman
Journal:  Health Aff (Millwood)       Date:  2020-08       Impact factor: 9.048

4.  Physician, Practice, and Patient Characteristics Associated With Biosimilar Use in Medicare Recipients.

Authors:  Emma Boswell Dean; Phyllis Johnson; Amelia M Bond
Journal:  JAMA Netw Open       Date:  2021-01-04

5.  Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.

Authors:  Mariana P Socal; Ge Bai; Gerard F Anderson
Journal:  JAMA Netw Open       Date:  2021-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.